Accelerate Diagnostics Inc expected to post a loss of 49 cents a share - Earnings Preview

Accelerate Diagnostics

02/05/2025 13:23

Accelerate Diagnostics Inc AXDX.OQ AXDX.O is expected to show a rise in quarterly revenue when it reports  results on May 6 (estimated) for the period ending March 31 2025

The Denver Colorado-based  company is expected to report a 2.7% increase in revenue to $3 million from $2.92 million a year ago, according to the estimate from one analyst, based on LSEG data.

​LSEG's mean analyst estimate for Accelerate Diagnostics Inc is for a loss of 49 cents per share.

The one available analyst rating on the shares is "strong buy".

The mean earnings estimate of analysts was unchanged in the last three months. ​

This summary was machine generated May 2 at 12:23 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)